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SUMMARY
Background
Crohn’s disease (CD) and ulcerative colitis (UC) are two pathotypes of inflammatory
bowel disease (IBD) with unique pathology, risk factors and significant morbidity.
Aim
To estimate incidence and identify IBD risk factors in a US military population, a
healthy subset of the US population, using information from the Millennium
Cohort Study.
Methods
Incident IBD was identified from medical encounters from 2001 to 2009 or by
self-report. Our primary risk factor of interest, infectious gastroenteritis, was iden-
tified from medical encounters and self-reported post-deployment health assess-
ments. Other potential risk factors were assessed using self-reported survey
responses and military personnel files. Hazard ratios were estimated using Cox
proportional hazards analysis.
Results
We estimated 23.2 and 21.9 diagnoses per 100 000 person-years, respectively, for
CD and UC. For CD, significant risk factors included [adjusted hazard ratio (aHR),
95% confidence interval]: current smoking (aHR: 2.7, 1.4–5.1), two life stressors
(aHR: 2.8, 1.4–5.6) and prior irritable bowel syndrome (aHR: 4.7, 1.5–15.2). There
was no significant association with prior infectious gastroenteritis. There was an
apparent dose–response relationship between UC risk and an increasing number of
life stressors. In addition, antecedent infectious gastroenteritis was associated with
almost a three-fold increase in UC risk (aHR: 2.9, 1.4–6.0). Moderate alcohol con-
sumption (aHR: 0.4, 0.2–0.6) was associated with lower UC risk.
Conclusions
Stressful conditions and the high risk of infectious gastroenteritis in deployment
operations may play a role in the development of IBD in military populations.
However, observed differences in risk factors for UC and CD warrant further
investigation.
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INTRODUCTION
Inflammatory bowel disease (IBD) comprises a group of
bowel diseases of likely immune-mediate aetiology and
primarily occurs in two forms, chronic inflammatory
enteritis [Crohn’s Disease(CD)] and chronic inflamma-
tory colitis [ulcerative colitis (UC)]. Incidence rates in
North America have been estimated to range from
approximately 2 to 15 cases per 100 000 person-years
for both forms with peak onset between the ages of 15
and 30 years.1–3 In contrast, throughout much of the
developing world, rates are lower; however, IBD inci-
dence appears to be increasing in those regions that are
becoming more westernised.4, 5 The symptoms of IBD
include abdominal pain, vomiting, diarrhoea, hema-
tochezia, weight loss and weight gain and treatments can
involve immunosuppression and/or surgery with direct
medical costs in the USA exceeding $1.8 billion,6 and
indirect costs due to lost work production alone esti-
mated to exceed $3.6 billion annually.7
The challenges of population-based epidemiologic
studies of IBD include confounding by co-morbid condi-
tions and/or limited data on risk factors and/or specific
study populations compromising validity and limiting
generalisability.8 One population that may be well-suited
to study disease incidence is active duty US military per-
sonnel. The US active duty military population repre-
sents a healthier segment of the general population with
almost unrestricted access to available medical care,
which makes them suitable for epidemiologic studies on
disease incidence and risk factors, due to the likely cap-
ture of these outcomes from the military health care sys-
tem. Prior studies in military populations have identified
important and unique risk factors, but have been limited
to data available in electronic medical records which
often lack detailed information on life stressors and
health risk behaviours that may be important in under-
standing the epidemiology of disease.9–11 To address
these limitations, we utilised a hypothesis-generating
approach in leveraging data from the Millennium Cohort
Study, a large prospective study of more than 200 000
military service members that includes a triennial survey
of health conditions, to describe IBD incidence and
assess potential risk factors not previously explored in
this population.
MATERIALS AND METHODS
Study population
Launched in 2001, the Millennium Cohort Study is a
prospective longitudinal study to investigate any impact
of military service among US military personnel even
after separation from military service. The methodology
has previously been described elsewhere.12–14 The cohort
contains four enrolment panels (Panel 1, 2001–2003,
N = 77 019; Panel 2, 2004–2006, N = 31 110; Panel 3,
2007–2008, N = 43 439; Panel 4, 2011–2013,
N = 50 052). Panel 1 was a population-based random
sample of the U.S. military in October 2000 with over-
sampling of Reserve/Guard personnel, women, and those
deployed to Bosnia, Kosovo or Southwest Asia. Panels 2,
3 and 4 targeted new accessions (1–5 years of military
service) with oversampling of Marines and women. Par-
ticipants completed a baseline survey and were resur-
veyed at approximately 3-year intervals. For purposes of
our study, we focused on responses to two questions:
whether the participant had been diagnosed by a health-
care provider with either 1) CD, or 2) UC or proctitis.
The population for this IBD study was defined as
active duty Millennium Cohort Study participants from
Panels 1 and 2 who completed a baseline questionnaire
(while still serving in the military) and at least one fol-
low-up questionnaire between 2001 and 2009. Partici-
pants with evidence of IBD at baseline, either by self-
report on the baseline survey or from Military Health
System medical encounter (ME) data (≥2 MEs within
365 days with one or more of the following International
Classification of Diseases, 9th Revision, Clinical Modifi-
cation (ICD-9-CM) codes: 555.0, 555.1, 555.9, 556.x),
were excluded from this analysis. Self-report of provider
diagnosed “ulcerative colitis or proctitis” was also exclu-
sionary because even though proctitis is not a type of
IBD, the survey question precluded disease differentia-
tion. In addition, participants who reported they had
received a diagnosis of every listed health outcome (pan-
endorsers) on any survey questionnaire were excluded as
were subjects with incomplete data for risk factors of
interest.
Incident IBD
Incident IBD was determined based on medical encoun-
ter data or self-report as follows. Active duty participants
with ≥2 MEs for IBD (ICD-9-CM codes 555.0, 555.1 and
555.9 for CD and ICD-9-CM code 556.x for UC, in any
diagnostic field) within a 365 day period were considered
incident IBD cases. Self-reported CD was defined as a
participant responding “yes” to having been diagnosed
with CD by a provider on a follow-up Millennium
Cohort Study questionnaire. Due to the inability to dif-
ferentiate UC and proctitis in the Millennium Cohort
Study questionnaire data, only medical encounter data
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were utilised to identify incident UC cases. For diagnoses
derived from medical encounter data only, the date of
the first of the two encounters was identified as the diag-
nosis date. For self-reported CD, respondents had the
option to report the year of diagnosis. If year of diagno-
sis was documented, we used the mid-point of the self-
reported year. However, if no year was reported, we used
the survey date for their first self-reported CD diagnosis.
In cases where a subject met both the medical encounter
definition and the self-reported definition of IBD, the
diagnosis date derived from medical encounter data was
preferentially used.
Primary risk factor of interest: antecedent infectious
gastroenteritis
Infectious gastroenteritis data were collected from both
ME data and self-reported post-deployment health
assessments. Medical encounters between the baseline
survey and IBD diagnosis (cases) or censor (noncases)
with an infectious gastroenteritis-associated ICD-9-CM
code (all 001 subgroups, 003.0, 003.9, all 004 subgroups,
all 008.0 subgroups, 008.43, 008.44, 005.4, 008.47,
008.49, 008.5, 009.0, 009.1, 009.2, 009.3, all 005.8 sub-
groups, 005.9, 006.0, 006.1, 006.2, 006.9, all 007 sub-
groups, all 008.6 subgroups, and 008.8) were defined as
infectious gastroenteritis episodes. In addition, self-
reported diarrhoea during or after deployment on a
post-deployment health assessment completed between
the baseline survey and censoring were considered infec-
tious gastroenteritis episodes. As with IBD, for diagnoses
of infectious gastroenteritis derived from medical
encounter data, the date of the first of the two encoun-
ters was identified as the diagnosis date. For self-
reported episodes of diarrhoea, the date of completion
of the post-deployment health assessment was used as
the diagnosis date.
Other risk factors
Demographic and military-specific data, including sex,
birth year, education, marital status, race/ethnicity,
branch of service, occupation, rank, military separation,
deployment status and number of deployments, were
obtained from Defense Manpower Data Center records
and the Millennium Cohort questionnaires. Body mass
index (BMI) was calculated from self-reported height
and weight. Behavioral and mental health characteristics,
including smoking, drinking, life stressors, depression,
anxiety or post-traumatic stress disorder (PTSD), as well
as self-reported medications for these conditions, were
also assessed from Millennium Cohort survey responses.
Detailed definitions of each of these risk factors have
been described elsewhere.15
Time censoring calculations
The date of the first survey’s submission was defined as
the start time for the period of observation. Noncases
were then censored differently for CD and UC analyses.
For UC, censoring at the earliest of four dates: date of
UC diagnosis; date of separation from military service;
date of death; end of study (31 December 2009). The use
of the survey-based diagnosis for CD complicated cen-
soring. Similar to UC, the date of diagnosis, the date of
death, and the end of the study were censoring events.
In contrast, for those who separated after completion of
their last survey, the censoring date was the date of sepa-
ration. For those who separated before completion of
their last survey, the date of the last Millennium Cohort
survey completion was the censor date.
Statistical analysis
Survival analyses were performed using the PHREG pro-
cedure in SAS (Version 9.3, SAS Institute, Cary, NC,
USA) for CD and UC, modelled separately. The primary
exposure of interest, antecedent infectious gastroenteritis,
was forced into all models as a time-varying covariate.
Forward selection with a P < 0.05 threshold was used
for all other risk factors entering into the model; all of
these variables were examined as fixed effects. Con-
founders of the infectious gastroenteritis-CD relationship
or infectious gastroenteritis-ulcerative colitis relationship
in their respective models were included if they changed
the IGE parameter estimate by 10% or more. Interac-
tions between infectious gastroenteritis and each covari-
ate in the model were examined. If an interaction term
was significant at P < 0.05, Akaike information criterion
was used to select between models with and without the
interaction term. If Akaike information criterion differ-
ence between two models was less than four, the model
without interaction term was selected for model parsi-
mony and interpretability.16 Proportional hazards
assumption was examined using Martingale residuals
and interaction with time methods.
RESULTS
Of the 108 129 participants from Panels 1 and 2 who
completed a baseline questionnaire, 203 pan-endorsers of
provider-based diagnoses on at least one survey were
excluded (Figure 1). We were unable to calculate an
accurate censoring time on an additional 39 723 partici-
pants, because they were not on active duty for the
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108 129 service members completed 
baseline surveys from Panels 1 and 2
Excluded 203 for “pan-endorsing,” meaning 
they self -reported on at least one survey that 
they were diagnosed by a healthcare provider 
with every condition listed
107 926 service members included
Excluded 39,723 who did not meet study 
definition of “active duty” (remained on active 
duty for the duration of the study, separated 
directly from active duty, or entered the 
Reserves after active duty only due to term  
fulfillment)
68 203 active duty participants
Excluded 18 999 with no follow-up survey
49 204 participants who responded to 
at least one follow-up survey
Excluded 4687 for not being “at risk” for IBD
328 had IBD at baseline
4359 separated from the military prior 
to completion of baseline survey
44 517 participants “at risk” for IBD
Excluded 3710 from Crohn’s disease 
analyses for incomplete covariate data
Excluded 3217 from ulcerative colitis 
analyses for incomplete covariate data
41 300 included in ulcerative colitis 
analyses (223 387.47 person-years)
40 807 included in Crohn’s disease 
analyses (246 673.48 person-years)
Figure 1 | Subject selection for analysis.
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entire course of study and did not have precise separa-
tion date. These subjects were excluded from the analy-
sis. Participants were also excluded if they failed to
complete a follow-up survey (n = 18 999) or had IBD at
baseline (n = 328), separated from the military before
the completion of the baseline survey (n = 4359), or had
missing values on risk factors of interest (UC: n = 3217;
CD: n = 3710). Compared to included subjects, excluded
subjects were older (19.8% vs. 8.9% born before 1960),
more commonly single (43.1% vs. 23.1%), in the Army
(52.1% vs. 40.4%), more commonly had life stressors
(77.1% vs. 57.5%), and more frequently had no deploy-
ment history at baseline (57.0% vs. 40.9%).
These exclusions yielded a final study population of
40 807 participants with 246 673.48 person-years of fol-
low-up for CD, and 41 300 participants with 223 387.47
person-years of follow-up for UC ulcerative colitis.
Demographic, military and behavioural characteristics
of study participants are shown in Table 1. Nearly, three
quarters of the study population were male (72.8%), with
the majority born between 1960 and 1979 (71.6%), mar-
ried (69.6% for CD and 70.6% for UC), with less than a
bachelor’s degree (69.7% for CD and 69.9% for UC), and
being of white, nonHispanic race/ethnicity (66.1 for CD
and 66.2% for UC). Approximately 40% of the study
population served in the Army, followed by the Air
Force, Navy/Coast Guard and Marine Corps. A majority
of participants were never smokers, followed by former
smokers and current smokers. Approximately half of the
participants reported moderate alcohol consumption,
and over 50% reported having one or more life stressors;
however, only a small proportion of participants
reported experiencing depression, anxiety/panic or
PTSD. With regard to military experience, approximately
60% of the participants had at least one deployment, and
about 26% of the participants reported combat exposure.
A total of 58 new onset CD cases were identified, for
an incidence of 23.15/100 000 person-years [95% CI
18.20–30.37] with approximately 80% identified from
either the medical encounter data only (21/58; 36.2%) or
the survey only (24/58; 41.4%). As shown in Table 2,
younger age [born 1980 or later, hazard ratio (HR):
2.07], service and supply occupation (HR: 3.52), anxiety
(HR: 2.62) and prior Irritable bowel syndrome (IBS)
(HR: 5.08) were all associated with significantly increased
CD risk. Both current (HR: 2.78) and past (HR: 1.54)
smoking were associated with an increased CD risk,
though only current smokers had a significantly
increased risk (P = 0.0011). An increasing number of life
stressors was also associated with an increased CD risk
with an apparent dose–response effect. Several psycho-
logical co-morbidities were associated with increased CD
risk, including anxiety syndrome (HR: 2.62) and PTSD
(HR: 1.82), though the latter was not significant. Infec-
tious gastroenteritis was not associated with a significant
increase in developing CD (HR: 1.05, 95% CI: 0.47–2.36)
though a nonsignificant increase in the effect estimate
(HR: 1.94, 95% CI: 0.70–5.41) was observed when limit-
ing to medical encounter only infectious gastroenteritis
episodes (data not shown). Being married (HR: 0.49)
was associated with a decreased CD risk compared to
being single. In addition, there was an inverse association
between BMI and CD risk with those classified as over-
weight or obese having lower CD risk (HR: 0.54, 95%
CI: 0.31–0.93 and HR: 0.36, 95% CI: 0.14–0.93 respec-
tively). Military deployments similarly appeared to be
associated with a decreased CD risk, though the effect
was not statistically significant. In the adjusted Cox pro-
portional hazards model, service and supply occupation
[adjusted hazard ratio (aHR): 3.32], current smoking
(aHR: 2.65), two life stressors (aHR: 2.75) and prior IBS
(aHR: 4.70) remained associated with a significantly
increased CD risk while being married (aHR: 0.53) and
divorced, widowed, legally separated (aHR: 0.12),
remained associated with a decreased CD risk.
There were 49 reported new onset UC cases, yielding
an estimated incidence of 21.94/100 000 person-years
(95% CI: 16.60–28.98). In univariate Cox models, similar
to CD, there were specific occupational risk factors with
work in electrical and equipment repair (univariate HR
3.43) associated with a significantly increased UC risk
(Table 2). In addition, there was an increasing UC haz-
ard ratio with increasing number of life stressors (1:
1.25, 2: 2.12, 3 + : 4.84). Documented infectious gas-
troenteritis was associated with an increased risk of UC
(HR: 2.62, 95% CI: 1.28–5.37), an effect that increased to
4.86 (95% CI: 2.14–11.05) when limiting analyses to only
medical encounter-related infectious gastroenteritis
events (data not shown). Similar to CD, prior IBS was
associated with increased UC risk (univariate HR: 3.71),
but unlike CD, this effect was not significant. Being of
younger age (born 1980 or later, HR: 0.20), married
(HR: 0.51) and moderate alcohol consumption (HR:
0.34) were associated with significantly decreased UC
risk. In contrast to CD, current smoking was associated
with a nonsignificantly decreased risk of UC, and a
slight, nonsignificantly increased UC risk was observed
among past smokers. Similar to CD, UC risk was lower
in subjects with prior deployments, though the effect was
not statistically significant.
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Table 1 | Overall descriptive characteristics of study population included for Crohn’s disease and ulcerative colitis
Characteristic
Crohn’s disease
(N = 40 807)
Ulcerative colitis
(N = 41 300)
n % n %
Gender
Male 29 711 72.8 30 071 72.8
Female 11 096 27.2 11 229 27.2
Birth year
Pre-1960 3588 8.8 3635 8.8
1960–1969 13 344 32.7 13 574 32.9
1970–1979 15 876 38.9 16 002 38.7
1980-present 7999 19.6 8089 19.6
Race/ethnicity
White, non-Hispanic 26 993 66.1 27 349 66.2
Black, non-Hispanic 5487 13.4 5553 13.4
Other 8327 20.4 8398 20.3
Marital status
Single 9693 23.8 9510 23.0
Married 28 413 69.6 29 177 70.6
Divorced, widowed, legally separated 2701 6.6 2613 6.3
Education
Less than a bachelor’s degree 28 423 69.7 28 875 69.9
Bachelor’s degree or higher 12 384 30.3 12 425 30.1
Panel (accession into cohort study)
2001–2003 30 329 74.3 30 701 74.3
2004–2006 10 478 25.7 10 599 25.7
Branch of service
Army 16 546 40.5 16 679 40.4
Navy/Coast Guard 9123 22.4 9197 22.3
Marine Corps 2576 6.3 2609 6.3
Air Force 12 562 30.8 12 815 31.0
Rank
Enlisted 30 118 73.8 30 438 73.7
Officer 10 689 26.2 10 862 26.3
Occupation
Combat specialist 7802 19.1 7 835 19.0
Functional support 8245 20.2 8 499 20.6
Service and supply 3475 8.5 3483 8.4
Healthcare 4554 11.2 4624 11.2
Electrical/mechanical equipment repair 5720 14.0 5766 14.0
Other 11 011 27.0 11 093 26.9
Separated
No 23 012 56.4 23 012 55.7
Yes 17 795 43.6 18 288 44.3
Smoking*
Never 23 586 57.8 23 896 57.9
Former 10 315 25.3 10 449 25.3
Current 6906 16.9 6955 16.8
Alcohol consumption†
Abstainer/light 16 947 41.5 16 809 40.7
Moderate 20 644 50.6 21 331 51.6
Heavy 3216 7.9 3160 7.7
BMI‡
Normal/underweight 13 612 33.4 13 708 33.2
Overweight 20 991 51.4 21 393 51.8
Obese 6204 15.2 6199 15.0
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In the adjusted Cox proportional hazards models, the
associations between UC and younger age (born 1980 or
later, aHR: 0.15), being married (aHR: 0.37), electrical/
mechanical equipment repair occupation (aHR: 2.96)
and moderate alcohol consumption (aHR: 0.35)
remained. Increasing number of life stressors continued
to demonstrate an association with increasing UC risk
which only reached significance in those with 3 +
stressors (aHR: 5.07, 95% CI: 1.93–13.30). In addition,
the risk of ulcerative colitis associated with antecedent
infectious gastroenteritis remained significant in the
adjusted Cox proportional hazards models (aHR: 2.90).
Significant interaction was observed between infectious
gastroenteritis and occupation; however, the data were
sparse due to the large number of occupation categories,
such that there, were UC cases with infectious
Table 1 | (Continued)
Characteristic
Crohn’s disease
(N = 40 807)
Ulcerative colitis
(N = 41 300)
n % n %
Number of life stressors§
0 18 310 44.9 17 662 42.8
1 15 981 39.2 16 251 39.3
2 4680 11.5 5221 12.6
3+ 1836 4.5 2166 5.2
Depression¶
Never 39 180 96.0 39 565 95.8
Ever 1627 4.0 1735 4.2
Anxiety and panic¶
Never 39 269 96.2 39 565 95.8
Ever 1538 3.8 1735 4.2
PTSD**
Never 38 600 94.6 38 941 94.3
Ever 2207 5.4 2359 5.7
Self-reported prescribed medication for mental health
No 38 766 95.0 39 102 94.7
Yes 2041 5.0 2198 5.3
Deployment experience††
Neither 10 853 26.6 11 009 26.7
Before OEF/OIF only 5726 14.0 5794 14.0
OEF/OIF only 14 837 36.4 15 004 36.3
Both 9391 23.0 9493 23.0
Combat exposure‡‡
Not deployed 16 579 41.1 16 803 41.4
Deployed, no combat 13 226 32.8 13 158 32.4
Deployed, combat 10 523 26.1 10 640 26.2
Multiple deployments
0 16 579 40.6 16 803 40.7
1 12 188 29.9 12 312 29.8
2+ 12 040 29.5 12 185 29.5
* Never: self-reported smoking <100 cigarettes in their lifetime. Past smoking: reporting successful smoking cessation, Current:
reported never trying to quit or unsuccessful at quitting.
† No/light: self-reported 0 drinks on a typical week, Moderate: self-reported an average of 1–7 drinks per week for women and 1
–14 per week for men, Heavy: self-reported an average of >7 drinks per week for women and >14 per week for men.
‡ Normal/underweight, <25; overweight, 25–29.9, obese, 30+.
§ Assessed using the Social Readjustment Rating Scale.46
¶ Assessed using responses to the Patient Health Questionnaire.
** Assessed using responses to the PTSD Checklist- Civilian Version.
†† Previous deployments include only Kosovo, Bosnia, SW Asia, and 1991 GW.
‡‡ MISSING: Combat exposures n = 479 (Crohn’s disease); n = 699 (Ulcerative colitis).
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Table 2 | Risk factors associated with Crohn’s disease and ulcerative colitis in the Millennium Cohort Study
participants between 2001 and 2009* (N = 40 807 and 41 300 for Crohn’s disease and ulcerative colitis
respectively)
Characteristic
Crohn’s disease Ulcerative colitis
N Univariate HR Adjusted HR N Univariate HR Adjusted HR
Antecedent infectious gastroenteritis
None 51 Ref Ref 38 Ref Ref
Any 7 1.05 (0.47–2.36) 1.10 (0.47–2.53) 11 2.62 (1.28–5.37) 2.90 (1.39–6.04)
Gender
Male 44 Ref 36 Ref
Female 14 0.91 (0.5–1.67) 13 1.04 (0.55–1.97)
Birth year
Pre-1960 6 1.35 (0.54–3.34) 3 0.63 (0.19–2.07) 0.73 (0.22–2.46)
1960–1969 16 0.90 (0.47–1.72) 17 0.75 (0.41–1.38) 0.85 (0.46–1.58)
1970–1979 21 Ref 27 Ref Ref
1980-present 15 2.07 (1.06–4.08) 2 0.20 (0.05–0.84) 0.15 (0.04–0.64)
Race/ethnicity
White non-Hispanic 42 Ref 33 Ref
Black non-Hispanic 6 0.69 (0.29–1.62) 6 0.87 (0.36–2.07)
Other 10 0.74 (0.37–1.47) 10 0.92 (0.45–1.86)
Marital status
Single 20 Ref Ref 15 Ref Ref
Married 37 0.49 (0.29–0.86) 0.53 (0.30–0.92) 31 0.51 (0.27–0.95) 0.37 (0.19–0.70)
Divorced, widowed, legally separated 1 0.14 (0.02–1.04) 0.12 (0.02–0.89) 3 0.53 (0.15–1.84) 0.35 (0.10–1.27)
Education
Less than a bachelor’s degree 40 1.08 (0.62–1.88) 0.65 (0.35–1.21) 37 1.56 (0.81–2.99)
Bachelor’s degree or higher 18 Ref Ref 12 Ref
Panel
2001–2003 44 Ref 40 Ref
2004–2006 14 1.52 (0.81–2.85) 9 0.93 (0.44–1.95)
Branch of service
Army 21 1.00 (0.52–1.92) 0.86 (0.44–1.68) 14 0.65 (0.32–1.31) 0.60 (0.29–1.24)
Navy/Coast Guard 17 1.49 (0.75–2.94) 1.19 (0.60–2.38) 15 1.30 (0.65–2.61) 1.18 (0.58–2.42)
Marine Corps 4 1.31 (0.44–3.93) 1.13 (0.37–3.42) 3 1.00 (0.29–3.43) 1.10 (0.32–3.80)
Air Force 16 Ref Ref 17 Ref Ref
Rank
Enlisted 43 Ref 39 Ref
Officer 15 1.15 (0.64–2.07) 10 1.67 (0.83–3.34)
Occupation
Combat specialist 8 Ref Ref 6 Ref Ref
Functional support 6 0.71 (0.25–2.04) 0.67 (0.23–1.95) 10 1.53 (0.56–4.21) 1.19 (0.43–3.30)
Service and supply 12 3.52 (1.44–8.62) 3.32 (1.35–8.21) 4 1.56 (0.44–5.53) 1.29 (0.36–4.60)
Healthcare 6 1.33 (0.46–3.83) 1.15 (0.39–3.37) 4 1.13 (0.32–4.01) 0.84 (0.23–3.01)
Electrical/mechanical equipment
repair
11 2.00 (0.81–4.98) 1.79 (0.69–4.65) 14 3.43 (1.32–8.94) 2.96 (1.12–7.82)
Other 15 1.39 (0.59–3.29) 1.25 (0.52–2.98) 11 1.36 (0.50–3.67) 1.12 (0.41–3.05)
Smoking‡
Never 24 Ref Ref 28 Ref Ref
Past 16 1.54 (0.82–2.90) 1.57 (0.82–2.98) 19 1.61 (0.90–2.88) 1.59 (0.88–2.89)
Current 18 2.78 (1.51–5.12) 2.64 (1.38–5.07) 2 0.28 (0.07–1.16) 0.25 (0.06–1.07)
Alcohol consumption§
No/light 27 Ref 33 Ref Ref
Moderate 25 0.74 (0.43–1.28) 15 0.34 (0.19–0.63) 0.35 (0.19–0.64)
Heavy 6 1.27 (0.52–3.07) 1 0.18 (0.02–1.29) 0.16 (0.02–1.19)
BMI¶
Normal/underweight 28 Ref 18 Ref
Overweight 25 0.54 (0.31–0.93) 27 0.89 (0.49–1.62)
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gastroenteritis in only two occupation categories, health-
care and electrical/mechanical equipment repair (data
not shown).
DISCUSSION
In our population of current and former military mem-
bers, we estimated an overall UC and CD incidence of
21.94 and 23.15/100 000 person-years respectively.
Importantly, subjects with missing data on important
risk factors for the survival analyses were excluded from
these estimates though their exclusion yielded no sub-
stantial change in overall incidence for either CD or UC
(data not shown). Several prior studies have estimated
the incidence of CD and UC in various populations with
comparable estimates.17 In the USA, studies reporting
CD and UC incidence in comparably aged populations
have estimated CD incidence between 5.7 and 28.4 per
100,000 person-years with a slightly higher incidence of
UC reported in some studies.1, 18, 19 We observed no
significant difference in the incidence of CD and UC in
our study. A single study has previously reported overall
IBD incidence (CD and UC) in this population at just
less than 30 cases per 100 000 person-years10; however,
that study was limited to medical encounters occurring
Table 2 | (Continued)
Characteristic
Crohn’s disease Ulcerative colitis
N Univariate HR Adjusted HR N Univariate HR Adjusted HR
Obese 5 0.36 (0.14–0.93) 4 0.45 (0.15–1.33)
Number of life stressors**
0 20 Ref Ref 17 Ref Ref
1 21 1.25 (0.68–2.30) 1.21 (0.66–2.25) 18 1.25 (0.64–2.42) 1.23 (0.63–2.40)
2 13 2.86 (1.42–5.75) 2.75 (1.35–5.62) 8 2.12 (0.91–4.91) 2.19 (0.93–5.16)
3+ 4 2.50 (0.85–7.32) 2.25 (0.75–6.75) 6 4.84 (1.90–12.33) 5.07 (1.93–13.30)
Depression syndrome ††
No 56 Ref 47 Ref
Yes 2 0.96 (0.23–3.92) 2 1.15 (0.28–4.72)
Anxiety syndrome††
No 53 Ref 48 Ref
Yes 5 2.62 (1.05–6.55) 1 0.55 (0.08–3.96)
PTSD‡‡
No 53 Ref 45 Ref
Yes 5 1.82 (0.73–4.55) 4 1.70 (0.61–4.72)
Self-reported prescribed medication for mental health
No 54 Ref 46 Ref
Yes 4 1.44 (0.52–3.97) 3 1.22 (0.38–3.92)
Deployments
0 26 Ref Ref 21 Ref
1 17 0.86 (0.47–1.58) 0.82 (0.44–1.53) 13 0.71 (0.35–1.42)
2+ 15 0.73 (0.39–1.38) 0.72 (0.37–1.40) 15 0.75 (0.39–1.46)
Prior IBS
No 55 Ref Ref 47 Ref
Yes 3 5.08 (1.59–16.23) 4.70 (1.46–15.15) 2 3.71 (0.90–15.28)
IBS, irritable bowel syndrome.
* Excludes pan endorsers and anyone who did not complete at least one follow-up survey.
‡ Never: self-reported smoking <100 cigarettes in their lifetime. Past smoking: reporting successful smoking cessation, Current:
reported never trying to quit or unsuccessful at quitting.
§ No/light: self-reported 0 drinks on a typical week, Moderate: self-reported an average of 1–7 drinks per week for women and 1
–14 per week for men, Heavy: self-reported an average of >7 drinks per week for women and >14 per week for men.
¶ Normal/underweight, <25; overweight, 25–29.9, obese, 30+.
** Assessed using the Social Readjustment Rating Scale.46
†† Assessed using responses to the Patient Health Questionnaire.
‡‡ Assessed using responses to the PTSD Checklist- Civilian Version.
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during the active duty service period which may account
for the lower rates than reported here.
On the basis of several prior lines of evidence, we took
a focused look at the role of infectious gastroenteritis in
increasing IBD risk. While we observed no association
between CD incidence and infectious gastroenteritis, we
did see an almost three-fold increase in UC incidence in
subjects with prior infectious gastroenteritis. Separate
studies have previously reported a positive association
between antecedent Campylobacter and Salmonella infec-
tion and IBD 20, 21 while others have noted an associa-
tion with nonspecific exposures such as those included
in our models.10, 22 While studies of the potential mech-
anisms underlying this association are in their infancy,
in vivo and in vitro data are emerging that may increase
understanding of these findings. To that end, recent data
show that C. jejuni facilitates the translocation of com-
mensal flora leading to the aberrant immune response
seen in IBD patients.23 In addition, data are emerging
that suggest a proliferation of anti-commensal T cells is
evident following an acute gastrointestinal (GI) infection
which coincides with a loss in regulatory T cells.24, 25
Furthermore, increased levels of antibodies directed at
commensal flora are evident in the serum of IBD
patients; however, similar commensal responses present
in healthy populations points to a more nuanced effect
that may be based on genetic predisposition, repeated
exposure or extra-intestinal exposures.24
In contrast to other studies, we found no association
between infectious gastroenteritis and CD.10, 20–22 This
may be due to nondifferential exposure misclassification;
however, studies using similar exposures and those
focused on Campylobacter and Salmonella reported com-
parable positive association between infectious gastroen-
teritis and both IBD pathotypes. Importantly, there were
differences in how incident CD and UC cases were iden-
tified. Specifically, incident CD was identified from both
the medical encounter data as well as an affirmative
response on the Millennium Cohort Study questionnaire.
In contrast, UC cases were limited to medical encounter
data. Given the prior report of 17.1% positive agreement
between CD-specific Millennium Cohort responses and
corresponding medical records,26 we re-ran our analyses
including only cases identified by medical encounter data
in an attempt to assess whether inclusion of self-reported
diagnosis introduced case-status misclassification. In that
re-analysis, we found a nonsignificant 1.5-fold increase
in CD risk among those with prior infectious gastroen-
teritis (data not shown). Similarly, we also assessed the
role of infectious gastroenteritis identified solely from
medical encounter data to minimise potential biases in
self-reported exposures. The adjusted HR for antecedent
infectious gastroenteritis in the UC model increased to
4.4 (95% CI: 1.9–10.0) and to 1.6 for CD (95% CI: 0.6–
4.6), though not statistically significant (data not shown).
While the mechanisms behind the association between
acute enteric infection and IBD are unclear, this is not
the only study to report this association.10, 20–22 It is
possible that the observation represents an increased risk
of infectious gastroenteritis (or even severe gastroenteri-
tis) in those with undiagnosed IBD. While this is feasi-
ble, other studies reporting this phenomenon have
described a delay in the observed effect (development of
IBD following infectious gastroenteritis) of more than
5 years.10, 20–22 In our study, the median time was
approximately 2.5 years. While again, this may represent
subclinical IBD that likelihood is reduced the more distal
in time from the antecedent infectious gastroenteritis
episode.
It has been argued that the association between ante-
cedent enteric infection and increased IBD risk may be
due to diagnostic misclassification due to increased cul-
turing in the IBD work-up.21 While this may in fact play
a role, the data to date are insufficient to support this
purported bias and carefully designed studies are needed
to assess the role of a surveillance bias and include the
clinical presentation of subjects at the time of culture.27
In our study, CD was most strongly linked to antece-
dent IBS after controlling for other risk factors (adjusted
HR: 4.70; P = 0.01); however, there was no association
with UC in the multivariable model. Garcia-Rodriguez
et al. similarly reported a strong association between
antecedent IBS and IBD, an effect that was more pro-
nounced for CD than UC.28 In addition, Porter et al.
previously described an eightfold increase in IBD risk in
those with IBS at baseline compared to those with no
evidence of IBS at baseline, an effect which was twice as
high for CD than UC.9 Others have also observed an
increase in organic GI disorders subsequent to
IBS9, 29, 30; however, the potential mechanisms underly-
ing this association remain poorly characterised. It may
be that an IBS diagnosis represents misdiagnosed IBD, a
potential effect that is confounded by the lack of a diag-
nostic test for functional bowel disorders.
Stress has been repeatedly evaluated as a potential risk
factor for CD and UC with varying results, likely due to
variability in study design and how stress is measured.31
We observed an increase in UC and CD in those with
more than one life stressor prior to disease. Furthermore,
for UC, the effect appeared to be a positive dose–
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response relationship with increasing UC risk corre-
sponding to an increasing number of life stressors. In a
case–control study of UC risk factors, Tocchi et al.
reported a fourfold increase in the prevalence of a stress-
ful life condition in 12 months prior to study enrolment;
however, due to the study design, a temporal relationship
could not be established.32 Lerebours et al. reported an
association between stressful life events with CD but not
UC; however, exposures were limited to the 6 month
period prior to the onset of symptoms, potentially bias-
ing effect estimates towards the null.33 It may be that the
effect we observed represents increasing symptoms in
undiagnosed patients subsequently leading to treatment
and diagnosis. Increasing symptoms following stress in
IBD patients has been reported previously and studies
have also reported an increase in IBD among those with
depression-like symptoms;34 however, we found no sig-
nificant effect of depression or anxiety on IBD risk.
Of specific interest in this population is the potential
effect of post-traumatic stress disorder (PTSD) in the
modulation of IBD risk. We reported a slight, albeit not
statistically significant, increase in UC and CD risk
among subjects with PTSD; however, the number of
cases with PTSD was quite low. O’Donovan et al.
recently reported on the increase in several autoimmune
disorders among US veterans of war in Iraq and Afgha-
nistan.35 This observation included a significant 1.3-fold
increase in the risk of IBD; however, the disease patho-
types were not differentiated. Our study was not pow-
ered to identify this effect size; nonetheless, our CIs
include these parameter estimates.
We observed several occupations with significantly
increased CD and UC risk. Specifically, being in a service
and supply category or occupation was associated with
more than a threefold increase in CD risk while a similar
magnitude of UC risk was observed in those whose
occupations included electrical and/or mechanical equip-
ment repair. Occupation risk factors for IBD were
recently summarised by Lesso et al.36 In particular, the
authors report several pathotype-specific risk factors;
however, the authors also note the considerable lack of
quantifiable exposure data and highlight the need for
prospective cohort studies with monitored exposures
over time. Importantly, such studies remain difficult for
relatively rare diseases and focused efforts to simply
describe an increased prevalence with specific occupa-
tions may guide additional such focused studies.
Smoking is a well-described risk factor for CD and a
protective factor for UC; we observed nearly a fourfold
increased risk in CD among current smokers and a
fourfold decreased risk of UC.31 We also saw a non-
significant 1.6-fold increase in CD and UC risk among
those who self-reported former smoking. This finding is
consistent with prior reports that increased CD risk con-
tinues many years after quitting smoking, though the
magnitude of the risk decreases.37, 38 Higuchi et al.
reported an increase in UC risk among women within
2 years of smoking cessation, an effect that persisted for
more than 10 years.37 Similarly, Jiang et al. reported cur-
rent smoking as a protective factor in UC (OR: 0.28,
P < 0.0001) while being an ex-smoker was a risk factor
(OR: 4.36, P = 0.008).39 Despite a previous report of the
relationship between smoking and IBD risk being more
pronounced in females than males,31 we observed similar
effects in our predominately male population. The reason
for the discrepant effects of cigarette smoking remains
elusive and more research in this area is needed in mili-
tary and other populations.
We observed an inverse dose–response in the risk of
UC among those reporting moderate and heavy alcohol
consumption and no significant association between
alcohol consumption and CD risk. Three prior studies
assessed the role of alcohol in IBD and found a similar
decrease in risk.39–41 The potential beneficial effect of
alcohol in preventing UC has been theorised to be asso-
ciated with phenols present in alcoholic drinks that may
inhibit pro-inflammatory cytokines;42 however, studies of
disease activity in IBD patients have reported an increase
in GI symptoms among UC patients consuming alcohol
due to increasing intestinal permeability and subsequent
antigenic exposure.43 Clearly, additional studies on mod-
erate and heavy alcohol consumption and IBD risk are
needed.
This study had some inherent limitations such as
potential misclassification from data obtained from
self-reported survey responses; however, many of the
questions embedded in the survey are standardised and
previously validated.13 In addition to self-reported expo-
sures, IBD was identified from electronic medical
encounter data. Importantly, these outcomes have not
been validated through medical record review. However,
they have been utilised in several other large epidemio-
logic studies in this population.10, 11 In addition, other
studies in similar populations have shown a high positive
predictive value in the use of these medical billing codes
to accurately identify those with IBD.44 We were unable
to exclude those with other conditions mimicking IBD,
such as coeliac disease or tropical sprue; however, these
outcomes are rare. Despite these limitations, this study
did utilise data from a population-based prospective
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cohort study, with time-varying covariates that enabled
estimation of disease incidence and risk factors.
While many of the findings reported here confirm
previously published literature on IBD risk factors, we
find these confirmatory results reassuring in the context
of the more novel findings we observed in this study. In
addition, we feel that ongoing IBD research in military
populations is of utmost importance. The US military
population is a cross-section of the general US popula-
tion. In addition, the majority of the Millennium Cohort
has separated from service and is now part of the civilian
population. Because a stratified random sample of eligi-
ble military personnel are invited to join the Millennium
Cohort Study without regard to any exposures or health
outcomes, internal comparison groups are readily avail-
able in this Cohort.
Our findings contribute to the growing body of litera-
ture on the incidence of and risk factors for inflamma-
tory bowel disease in a young, healthy subset of the US
population. In addition to highlighting previously
described epidemiologic risk factors, we were able to
quantify the role of selected life stressors, PTSD and
antecedent infectious gastroenteritis on IBD risk. These
are important characteristics to address in this popula-
tion given operational deployments, often in combat set-
tings, and the high risk of infectious gastroenteritis
during these operations.45 Clearly, additional well-
designed focused research is needed and may include
expansion to additional survey panels within the Millen-
nium Cohort Study, enhanced characterisation of life
stressors and more expanded data on exposures and clin-
ical presentation of disease.
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